The pressure is mounting on Roche after Swiss rival Sandoz filed a US biosimilar of cancer and inflammatory diseases drug rituximab, closely behind a rival from Teva and Celltrion. Rituxan ...

Celltrion’s biosimilar marketing strategy in Europe has got seriously confusing after the firm asked to market its rituximab near-copy under four different brands. Its biosimilar of Roche’s ...

A final approval is expected soon. Subject to approval, the rituximab biosimilar will further contribute to revenues. RDY also markets Hervycta (trastuzumab), a biosimilar of Roche’s Herceptin ...

Rituxan (rituximab) is not safe to receive while pregnant or breastfeeding. Certain factors, including the risk of fetal harm, may determine whether you should receive Rituxan treatment during ...

Dr. Reddy’s launches drug-free migraine management device in Europe DRL_RI is being developed as a biosimilar of MabThera (Rituximab), a cluster of differentiation 20 (CD20) directed cytolytic ...